We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLYS icon
1426
Qualys
QLYS
$6.42B
-23,703
Closed -$2.47M
QTWO icon
1427
Q2 Holdings
QTWO
$3.96B
-24,812
Closed -$2.13M
RCKT icon
1428
Rocket Pharmaceuticals
RCKT
$399M
-61,872
Closed -$1.3M
REGN icon
1429
Regeneron Pharmaceuticals
REGN
$83.2B
-54,475
Closed -$34M
RGEN icon
1430
Repligen
RGEN
$9.21B
-2,924
Closed -$361K
RGLD icon
1431
Royal Gold
RGLD
$19.8B
-26,277
Closed -$3.27M
RGP icon
1432
Resources Connection
RGP
$145M
-25,122
Closed -$301K
RL icon
1433
Ralph Lauren
RL
$24.3B
-9,026
Closed -$655K
RMAX icon
1434
RE/MAX Holdings
RMAX
$244M
-11,412
Closed -$359K
RMBS icon
1435
Rambus
RMBS
$10.4B
-15,138
Closed -$230K
RNAM
1436
DELISTED
Avidity Biosciences
RNAM
-35,182
Closed -$994K
RPTX
1437
DELISTED
Repare Therapeutics
RPTX
-29,087
Closed -$902K
RUSHA icon
1438
Rush Enterprises Class A
RUSHA
$6.23B
-16,117
Closed -$297K
RYN icon
1439
Rayonier
RYN
$6.52B
-9,790
Closed -$220K
SAIA icon
1440
Saia
SAIA
$9.5B
-5,149
Closed -$572K
SCL icon
1441
Stepan Co
SCL
$1.47B
-8,213
Closed -$797K
SEIC icon
1442
SEI Investments
SEIC
$12.6B
-6,026
Closed -$331K
SF
1443
Stifel
SF
$12.7B
-21,026
Closed -$442K
SFIX
1444
Stitch Fix
SFIX
$530M
-38,187
Closed -$952K
SFNC icon
1445
Simmons First National
SFNC
$3.4B
-145,369
Closed -$2.49M
SGMO
1446
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-83,826
Closed -$751K
SHG icon
1447
Shinhan Financial Group
SHG
$34.7B
-10,547
Closed -$254K
SMPL icon
1448
Simply Good Foods
SMPL
$955M
-106,845
Closed -$1.98M
SMTC icon
1449
Semtech
SMTC
$12.2B
-24,398
Closed -$1.27M
SO icon
1450
Southern Company
SO
$105B
-12,009
Closed -$623K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.